UBS Group’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Sell |
33,375
-39,327
| -54% | -$273K | ﹤0.01% | 5391 |
|
|
2025
Q1 | $617K | Sell |
72,702
-59,659
| -45% | -$507K | ﹤0.01% | 4539 |
|
|
2024
Q4 | $1.85M | Buy |
132,361
+120,295
| +997% | +$1.68M | ﹤0.01% | 3777 |
|
|
2024
Q3 | $273K | Sell |
12,066
-3,869
| -24% | -$87.6K | ﹤0.01% | 4481 |
|
|
2024
Q2 | $323K | Buy |
15,935
+5,953
| +60% | +$120K | ﹤0.01% | 4232 |
|
|
2024
Q1 | $249K | Sell |
9,982
-1,168
| -10% | -$29.1K | ﹤0.01% | 4564 |
|
|
2023
Q4 | $202K | Sell |
11,150
-155
| -1% | -$2.8K | ﹤0.01% | 4599 |
|
|
2023
Q3 | $227K | Sell |
11,305
-1,307
| -10% | -$26.3K | ﹤0.01% | 4181 |
|
|
2023
Q2 | $322K | Sell |
12,612
-1,280
| -9% | -$32.7K | ﹤0.01% | 4147 |
|
|
2023
Q1 | $295K | Buy |
13,892
+950
| +7% | +$20.2K | ﹤0.01% | 4073 |
|
|
2022
Q4 | $383K | Sell |
12,942
-15,533
| -55% | -$460K | ﹤0.01% | 3902 |
|
|
2022
Q3 | $662K | Buy |
28,475
+15,509
| +120% | +$361K | ﹤0.01% | 3158 |
|
|
2022
Q2 | $218K | Buy |
12,966
+4,082
| +46% | +$68.6K | ﹤0.01% | 3871 |
|
|
2022
Q1 | $389K | Buy |
8,884
+7,992
| +896% | +$350K | ﹤0.01% | 3919 |
|
|
2021
Q4 | $54K | Buy |
892
+46
| +5% | +$2.79K | ﹤0.01% | 5728 |
|
|
2021
Q3 | $35K | Sell |
846
-869
| -51% | -$36K | ﹤0.01% | 5497 |
|
|
2021
Q2 | $52K | Buy |
1,715
+1,363
| +387% | +$41.3K | ﹤0.01% | 5330 |
|
|
2021
Q1 | $11K | Buy |
352
+118
| +50% | +$3.69K | ﹤0.01% | 6819 |
|
|
2020
Q4 | $4K | Sell |
234
-261
| -53% | -$4.46K | ﹤0.01% | 6864 |
|
|
2020
Q3 | $9K | Sell |
495
-1,790
| -78% | -$32.5K | ﹤0.01% | 6038 |
|
|
2020
Q2 | $36K | Buy |
+2,285
| New | +$36K | ﹤0.01% | 5293 |
|
|
2019
Q3 | – | Sell |
-1,718
| Closed | -$17K | – | 6992 |
|
|
2019
Q2 | $17K | Buy |
+1,718
| New | +$17K | ﹤0.01% | 5846 |
|